메뉴 건너뛰기




Volumn 58, Issue 6, 2009, Pages 888-

A possible link between TIMP-1 induction and response to infliximab

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; INFLIXIMAB; MITOGEN ACTIVATED PROTEIN KINASE P38; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR;

EID: 66649086498     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.167296     Document Type: Letter
Times cited : (5)

References (6)
  • 1
    • 36749070996 scopus 로고    scopus 로고
    • Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor alpha agents
    • Nesbitt A, Fossati G, Bergin M, et al. Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor alpha agents. Inflamm Bowel Dis 2007;13:1323-1332
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 1323-1332
    • Nesbitt, A.1    Fossati, G.2    Bergin, M.3
  • 4
    • 0037093877 scopus 로고    scopus 로고
    • P38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease
    • Waetzig GH, Seegert D, Rosenstiel P, et al. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 2002;168:5342-5351 (Pubitemid 34496003)
    • (2002) Journal of Immunology , vol.168 , Issue.10 , pp. 5342-5351
    • Waetzig, G.H.1    Seegert, D.2    Rosenstiel, P.3    Nikolaus, S.4    Schreiber, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.